Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs

Journal of Cerebral Blood Flow and Metabolism

Volumn 21, Issue 9, 2001, Pages 1013-1033

  Bruno, Valeria ^a   Battaglia, Giuseppe ^a   Copani, Agata ^b   D'Onofrio, Mara ^a   Di Iorio, P ^c   De Blasi, Antonio ^a   Melchiorri, Daniela ^d   Flor, Peter J ^e   Nicoletti, Ferdinando ^a,d  

^a IRCCS NEUROMED   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e NOVARTIS PHARMA AG   (Switzerland)

Author keywords

mGlu receptors; Neuroprotection; Subtype selective ligands

Indexed keywords

1 AMINO 1,5 INDANDICARBOXYLIC ACID; 2 (2,3 DICARBOXYCYCLOPROPYL)GLYCINE; 2 AMINO 2 (2 CARBOXYCYCLOPROPYL) 3 (XANTHEN 9 YL)PROPIONIC ACID; 2 AMINO 4 (2,2 DIPHENYLETHYL)PENTANE 1,5 DIOIC ACID; 2 AMINO 4 PHOSPHONOBUTYRIC ACID; 2 CHLOROHYDROXYPHENYLGLYCINE; 2 METHYL 6 (2 PHENYLVINYL)PYRIDINE; 2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; 3 HYDROXYPHENYLGLYCINE; 3,5 DIHYDROXYPHENYLGLYCINE; 4 (4,4 DIPHENYLBUTYL)GLUTAMIC ACID; 4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; 4 CARBOXY 2 METHYLPHENYLGLYCINE; 4 PHOSPHONOPHENYLGLYCINE; 6 METHYL 2 PHENYLAZO 3 PYRIDINOL; 6A NAPHTHALEN 2 YLMETHYL 5 METHYLIDENHEXAHYDROCYCLOPENTA[C]FURAN 1 ON; 7 (HYDROXYIMINO)CYCLOPROPA[B]CHROMEN 1A CARBOXYLATE ETHYL ESTER; ALPHA METHYL 2 AMINO 4 PHOSPHONOBUTANOIC ACID; ALPHA METHYLSERINE O PHOSPHATE; BAY 36 7620; EGLUMETAD; GLUTAMATE RECEPTOR AGONIST; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR ANTAGONIST; N ACETYLASPARTYLGLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROPROTECTIVE AGENT; PHOSPHOSERINE; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN ISCHEMIA; DEGENERATIVE DISEASE; DRUG ACTIVITY; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; NERVE INJURY; NEUROPROTECTION; PRIORITY JOURNAL; REVIEW; SEIZURE;

EID: 0034852645     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004647-200109000-00001     Document Type: Review

References (206)

1. Anti-epileptogenic and anticonvulsant activity of L-2-amino-4-phosphonobutyrate, a presynaptic glutamate receptor agonist
2. Deficient cerebellar long-term depression and impaired motor learning in mGluR1 mutant mice
3. Activation of NMDA receptors reverses desensitization of mGluR5 in native and recombinant systems
4. The functional anatomy of basal ganglia disorders
5. Beta-amyloid-induced apoptosis of cerebellar granule cells and cortical neurons: Exacerbation by selective inhibition of group-I metabotropic glutamate receptors
6. Activation of group I metabotropic glutamate receptors reduces neuronal apoptosis but increases necrotic cell death in vitro
7. Differential distribution of metabotropic glutamate receptors 1a, 1b, and 5 in the rat spinal cord
8. Metabotropic glutamate receptors negatively coupled to adenylate cyclase inhibit N-methyl-D-aspartate receptor activity and prevent neurotoxicity in mesencephalic neurons in vitro
9. Dendritic and axonal targeting of type 5 metabotropic glutamate receptor is regulated by homer 1 protein and neuronal excitation
10. A novel class of antagonists for metabotropic glutamate receptors, 7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxylates
11. Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus
12. Selective activation of group-1I metabotropic glutamate receptors is protective against excitotoxic neuronal death
13. Selective blockade of type-I metabotropic glutamate receptors induce neuroprotection by enhancing GABAergic transmission
14. The metabotropic glutamate receptor (mGluR1 alpha) is concentrated at perisynaptic membrane of neuronal subpopulations as detected by immunogold reaction
15. Selective activation of group II mGluRs with LY354740 does not prevent neuronal excitotoxicity
16. Expression and signaling of group I metabotropic glutamate receptors in astrocytes and microglia
17. Loss of hilar mossy cells in Ammon's horn sclerosis
18. Neuroprotective effects of a systemically active group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia
19. LY379268, a potent and selective group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal, cerebral ischaemia
20. Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: Investigations into possible mechanism of action in vivo
21. Comparative effect of L-CCG-I, DCG-IV and γ-carboxyl-L-glutamate on all cloned metabotropic glutamate receptor subtypes
22. Homer: A protein that selectively binds metabotropic glutamate receptors
23. Protective effect of the metabotropic glutamate receptor agonist, DCG-IV, against excitotoxic neuronal death
24. Activation of class II or class III metabotropic glutamate receptors protects cultured cortical neurons against excitotoxic degeneration
25. Activation of metabotropic glutamate receptors coupled to inositol phospholipid hydrolysis amplifies NMDA-induced neuronal degeneration in cultured cortical cells
26. Activation of group III metabotropic glutamate receptors is neuroprotectivc in cortical cultures
27. The neuroprotective activity of group-II metabotropic glutamate receptors requires new protein synthesis and involves a glial-neuronal signaling
28. Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta
29. Neuroprotective activity of the potent and selective mGlu1a metabotropic glutamate receptor antagonist, (+)2-methyl-4-carboxyphenylglycine (LY367385): Comparison with LY367366, a broader spectrum antagonist with equal affinity for mGlu1a and mGlu5 receptors
30. Selective activation of mGlu4 metabotropic glutamate receptors is protective against excitotoxic neuronal death
31. Selective blockade of metabotropic glutamate receptor subtype 5 is neuroprotective
32. An activity-dependent switch from facilitation to inhibition in the control of excitotoxicity by group-I metabotropic glutamate receptors
33. The inibitory mGluR agonist, S-4-carboxy-3-hydroxy-phenylglycine selectively attenuates NMDA neurotoxicity and oxygen-glucose deprivation-induced neuronal death
34. Up-regulation of a serine protease inhibitor in astrocytes mediates the neuroprotective activity of transforming growth factor-β1
35. G-protein activation by metabotropic glutamate receptors reduces spike frequency adaptation in neocortical neurons
36. Modulation of synaptic transmission and differential localisation of mGluRs in cultured hippocampal autapses
37. Protection of neonatal rat brain from hypoxic-ischemic injury by LY379268, a group II metabotropic glutamate receptor agonist
38. Seizures and neuronal damage induced in the rat by activation of group I metabotropic glutamate receptors with their selective agonist 3,5-dihydroxyphenylglycine
39. BAY36-7620: A potent non-competitive mGlu1 receptor antagonist with inverse agonist activity
40. Increased expression of neuronal nitric oxide synthase splice variants in reactive astrocytes of amyotrophic lateral sclerosis human spinal cord
41. Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene
42. Transforming growth factor-beta protects human neurons against beta-amyloid-induced injury
43. Anticonvulsant activity of a metabotropic glutamate receptor 8 preferential agonist, (R,S)-4-phosphonophenylglycine
44. Excitotoxic cell death
45. Group-I mGluR activation turns on a voltage-gated inward current in hippocampal pyramidal cells
46. Activation of Al adenosine and mGlu3 metabotropic glutamate receptors enhances the release of nerve growth factor and S-100β protein from cultured astrocytes
47. Homer1c/Vesl-1L modulates the cell surface targeting of metabotropic glutamate receptor type 1 alpha: Evidence for an anchoring function
48. 2-Methyl-4-carboxyphenylglycine (LY367385) selectively antagonizes metabotropic glutamate mGluR1 receptors
49. Plasticity of excitatory amino acid transporters in experimental epilepsy
50. Activation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by beta-amyloid peptide
51. Activation of metabotropic glutamate receptors prevents neuronal apoptosis in culture
52. The metabotropic glutamate receptor mGlu5 controls the onset of developmental apoptosis in cultured cerebellar neurons
53. Mitotic signalling by β-amyloid causes neuronal death
54. Gangliosides in the protection against glutamate excitotoxicity
55. Isolation and analysis of splice variants of the rat metabotropic glutamate receptors, mGluR7 and mGluR8
56. The human N-methyl-D-aspartate receptor 2C subunit: Genomic analysis, distribution in human brain, and functional expression
57. Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism
58. Molecular determinant of metabotropic glutamate receptor signaling
59. Reduced function of L-AP4-sensitive metabotropic glutamate receptors in human epileptic sclerotic hippocampus
60. Excitotoxic injury of the neostriatum: A model for Huntington's disease
61. Insulin-like growth factor and potassium depolarization maintain neuronal survival by distinct pathways: Possible involvement of PI 3-kinase in IGF-1 signaling
62. The role of excitotoxicity in neurodegenerative disease: Implications for therapy
63. Transforming growth factor-beta1 as a regulator of the serpins/t-PA axis in cerebral ischemia
64. A novel, competitive mGlu5 receptor antagonist (LY344545) blocks DHPG-induced potentiation of NMDA responses but not the induction of LTP in rat hippocampal slices
65. Neuroprotection mediated by group-II metabotropic glutamate receptors involves the activation of the MAP kinase pathway and requires the induction of TGF-β1
66. Alpha-actinin-2 in rat striatum: Localization and interaction with NMDA glutamate receptor subunits
67. A novel metabotropic glutamate receptor expressed in the retina and olfactory bulb
68. Molecular cloning, functional expression, pharmacological characterization and chromosomal localization of the human metabotropic glutamate receptor type 3
69. Neuroprotective effects of group III mGluR in traumatic neuronal injury
70. 2+ stores and ion channels in neurons
71. Activation of the extracellular signal-regulated kinase 2 by metabotropic glutamate receptors
72. Transforming growth factorbetas in neurodegenerative disease
73. Molecular cloning, functional expression and pharmacological characterization of the human metabotropic glutamate receptor type 2
74. Molecular cloning, functional expression and pharmacological characterization of the human metabotropic glutamate receptor type 4
75. The C-terminal domain of the mGluR1 metabotropic glutamate receptor affects sensitivity to agonists
76. A novel splice variant of a metabotropic glutamate receptor, human mGluR7b
77. Long-lasting potentiation of epileptiform bursts by group I mGluRs is NMDA receptor independent
78. (R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist is anticonvulsive and neuroprotective in vivo
79. 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist
80. (+)-4-Phosphonophenylglycine (PPG) a new group III selective metabotropic glutamate receptor agonist
81. Multiple presynaptic metabotropic glutamate receptors modulate excitatory and inhibitory synaptic transmission in hippocampal area CA1
82. No association found between polymorphisms in genes encoding mGluR7 and mGluR8 and idiopathic generalised epilepsy in a case control study
83. SMI-32 antibody against non-phosphorylated neurofilaments identifies a subpopulation of cultured cortical neurons hypersensitive to kainate toxicity
84. Activation of metabotropic glutamate receptors by L-AP4 stimulates survival of rat cerebellar granule cells in culture
85. Inhibition of hippocampal kindling by metabotropic glutamate receptor antisense oligonucleotides
86. Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity
87. Anxiolytic and side-effect profile of LY354740: A potent, highly selective, orally active agonist for group II metabotropic glutamate receptors
88. TGF-beta 1 protects hippocampal neurons against degeneration caused by transient global ischemia. Dose-response relationship and potential neuroprotective mechanisms
89. The mGlu receptor ligand (S)-4C3HPG protects neurons after global ischaemia in gerbils
90. Distinct influence of the group III metabotropic glutamate receptor agonist (R,S)-4phosphonophenylglycine [(R,S)-PPG] on different forms of neuronal damage
91. Positive feedback of glutamate exocytosis by metabotropic presynaptic receptor stimulation
92. Rapid desensitization of the presynaptic metabotropic receptor that facilitates glutamate exocytosis
93. Functional switch from facilitation to inhibition in the presynapticcontrol of glutamate release by metabotropic glutamate receptors
94. A novel metabotropic glutamate receptor agonist: Marked depression of monosynaptic excitation in the newborn rat isolated spinal cord
95. Actions of two new antagonists showing selectivity for different sub-types of metabotropic glutamate receptor in the neonatal rat spinal cord
96. Selective abolition of the NMDA component of long-term potentiation in mice lacking mGluR5
97. A "calcium set-point hypothesis" of neuronal dependence on neurotrophic factors
98. Molecular, functional, and pharmacological characterization of the metabotropic glutamate receptor type 5 splice variants: Comparison with mGluR1
99. Homer proteins regulate coupling of group I metabotropic glutamate receptors to N-type calcium and M-type potassium channels
100. Control of calcium oscillations by phosphorylation of metabotropic glutamate receptors
101. Neuroprotective action of novel and potent ligands of group-I and group-II metabotropic glutamate receptors
102. Neuroprotection by metabotropic glutamate receptor agonists: LY354740, LY379268 and LY389795
103. Decreased sensitivity to group III mGluR agonists in the lateral perforant path following kindling
104. Selective group II glutamate metabotropic receptor agonist LY354740 attenuates pentylentetrazole- and picrotoxin-induced seizures
105. Roles of group II metabotropic glutamate receptors in modulation of seizure activity
106. LY354740, a group II metabotropic glutamate receptor agonist with potential antiparkinsonian properties in rats
107. Structural basis of glutamate recognition by dimeric metabotropic glutamate receptor
108. Molecular diversity of the NMDA receptor channel
109. mGluR7-like metabotropic glutamate receptors inhibit NMDA-mediated excitotoxicity in cultured mouse cerebellar granule neurons
110. Effects of the selective metabotropic glutamate agonist LY354740 in a rat model of permanent ischaemia
111. HmGlu1d, a novel splice variant of the human type I metabotropic glutamate receptor
112. The changing landscape of ischemic brain injury mechanisms
113. Astrocytes interact intimately with degenerating motor neurons in mouse amyotrophic lateral sclerosis (ALS)
114. Up-regulation of the metabotropic glutamate receptor mGluR4 in hippocampal neurons with reduced seizure vulnerability
115. Cloning of the cDNA for the human NMDA receptor NR2C subunit and its expression in the central nervous system and periphery
116. The metabotropic glutamate receptor system protects against ischemic free radical programmed cell death in rat brain endothelial cells
117. CPCCOEt, a noncompetitive metabotropic glutamate receptor 1 antagonist, inhibits receptor signaling without affecting glutamate binding
118. Differential plasma membrane distribution of metabotropic glutamate receptors mGluR1 alpha, mGluR2 and mGluR5, relative to neurotransmitter release sites
119. Activation of the metabotropic glutamate receptor is neuroprotective during nitric oxide toxicity in primary hippocampal neurons of rats
120. Group I and group III metabotropic glutamate receptor subtypes provide enhanced neuroprotection
121. Glutamate-induced neuronal death in primary cultures of cerebellar granule cells: Protection by synthetic derivatives of endogenous sphingolipids
122. Abusive stimulation of excitatory amino acid receptors: A strategy to limit neurotoxicity
123. Neuroprotective action of the pineal hormone melatonin against excitotoxicity. Receptor abusedependent antagonism (RADA)
124. Metabotropic glutamate receptors regulate N-methyl-D-aspartate-mediated synaptic transmission in nucleus accumbens
125. The metabotropic glutamate receptor agonist 1S,3R-ACPD selectively potentiates N-methyl-D-aspartate-induced brain injury
126. Seizures and brain injury in neonatal rats induced by 1S, 3R-ACPD, a metabotropic glutamate receptor agonist
127. Emerging insights into the genesis of epilepsy
128. Role of group-I metabotropic glutamate receptors in the pattering of epileptiform activities in vitro
129. Group I mGluR-mediated silent induction of longlasting epileptiform discharges
130. Gp120-induced neurotoxicity in hippocampal pyramidal neuron cultures: Protective action of TGF-beta1
131. Stimulation of phosphoinositide hydrolysis by trans-(+/-)-ACPD is greatly enhanced when astrocytes are cultured in a serum-free defined medium
132. Molecular cloning and the functional expression of two isoforms of human metabotropic glutamate receptor subtype 5
133. Interaction of Vesl1L/Homer 1c with syntaxin 13
134. Agonists for metabotropic glutamate receptors in the rat delay recovery from halothane anesthesia
135. Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): A potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties
136. Oxygen or glucose deprivation-induced neuronal injury in cortical cell cultures is reduced by tetanus toxin
137. Involvement of the carboxy-terminal region in modulation by TPA of the NMDA receptor channel
138. Evidence for metabotropic glutamate receptor activation in the induction of depolarizationinduced suppression of inhibition in hippocampal CA1
139. Evidence that functional glutamate receptors are not expressed on rat or human cerebromicrovascular endothelial cells
140. mGluR5 antagonists 2-methyl-6-(phenylethynyl)-pyridine and (E)-2-methyl-6-(2-phenylethenyl)pyridine reduce traumatic neuronal injury in vitro and in vivo by antagonizing N-methyl-D-aspartate receptors
141. Metabotropic glutamate receptors: Synaptic transmission, modulation, and plasticity
142. Excitatory amino acid recognition sites coupled with inositol phospholipid metabolism: Developmental changes and interaction with aladrenoceptors
143. Metabotropic glutamate receptors: A new target for the therapy of neurodegenerative disorders?
144. Group-I metabotropic glutamate receptors: Hypotheses to explain their dual role in neurotoxicity and neuroprotection
145. Interaction between the C terminus of NMDA receptor subunits and multiple members of the PSD-95 family of membrane-associated guanylate kinases
146. Subsynaptic segregation of metabotropic and ionotropic glutamate receptors as revealed by immunogold localization
147. The ligand-binding domain in metabotropic glutamate receptors is related to bacterial peryplasmic binding proteins
148. Molecular characterization of a new metabotropic glutamate receptor mGluR7 coupled to inhibitory cyclic AMP signal transduction
149. Selective mGluR5 antagonists MPEP and SIB-1893 decrease NMDA or glutamate-mediated neuronal toxicity through actions that reflect NMDA receptor antagonism
150. Group I metabotropic glutamate receptor agonist causes neurodegeneration in rat hippocampus
151. (1S,3R)-ACPD protects synaptic transmission from hypoxia in hippocampal slices
152. The role of group I and group II metabotropic glutamate receptors in modulation of striatal NMDA and quinolinic acid toxicity
153. Subsynaptic localization of group I metabotropic glutamate receptors at glutamatergic synapses in monkey striatum
154. Switch in glutamate receptor subunit gene expression in CA1 subfield of hippocampus following global ischemia in rats
155. 1-Aminoindan-1,5-dicarboxylic acid and (S)-(+)-2-(3'-carboxyicyclo(1.1.1.)pentyl)-glycine, two mGlu1 receptor-preferring antagonists, reduce neuronal death in in vitro and in vivo models of cerebral ischemia
156. Protection with metabotropic glutamate 1 receptor antagonists in models of ischemic neuronal death: Time-course and mechanisms
157. 1-Aminoindan-1,5-dicarboxilic acid: A novel antagonist of phospholipase C-linked metabotropic glutamate receptors
158. The metabotropic glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations
159. The metabotropic glutamate receptors: Structure and functions
160. Enhancement of NMDA responses by group-I metabotropic glutamate receptor activation in striatal neurones
161. Cell-type specificity of mGluR activation in striatal neuronal subtypes
162. Attenuation of excitatory amino acid toxicity by metabotropic glutamate receptor agonists and aniracetam in primary cultures of cerebellar granule cells
163. 2+ concentration and excitotoxicity in cultured cerebellar graniule cells: Pivotal role of protein kinase C
164. Activation of multiple metabotropic glutamate receptor subtypes prevents NMDA-induced excitotoxicity in rat hippocampal slices
165. Reversal of glutamate excitotoxicity by activation of PKC-associated metabotropic glutamate receptors in cerebellar granule cells relies on NR2C subunit expression
166. Neuroprotection by metabotropic glutamate receptor agonists on kainate-induced degeneration of motor neurons in spinal cord slices from adult rat
167. Regulation of neuronal Bcl-2 protein expression and calcium homeostasis by transforming growth factor type beta confers wide-ranging protection on rat hippocampal neurons
168. Opposite effects of TGF-beta1 on rapidly-and slowly triggered excitotoxic injury
169. Protective effect of transforming growth factor-β1 on β-amyloid neurotoxicity in rat hippocampal neurons
170. Regulation of the cellular expression of secretory and cytosolic phospholipases A2, and cyclooxygenase-2 by peptide growth factors
171. Neuroprotection by group I metabotropic glutamate receptor antagonists in forebrain ischemia of gerbil
172. Transforming growth factor-β protects human hNT cells from degeneration induced by β-amyloid peptide: Involvement of the TGF-β type II receptor
173. Switch from facilitation to inhibition of excitatory synaptic transmission by the desensitization of group-I mGluRs in the rat hippocampus
174. A transforming growth factor-beta antagonist unmasks the neuroprotective role of this endogenous cytokine in excitotoxic and ischemic brain injury
175. Neuroprotection against hypoxic/hypoglycaemic injury after the insult by the group III metabotropic glutamate receptor agonist (R, S)-4-phosphonophenylglycine
176. Activation of hippocampal metabotropic excitatory amino acid receptors leads to seizures and neuronal damage
177. The activation of metabotropic glutamate receptors protects nerve cells from oxidative stress
178. Contributions of mGlu1 and mGlu5 receptors to interactions with N-methyl-D-aspartate receptor-mediated responses and nociceptive sensory responses of rat thalamic neurons
179. Postsynaptic organization and regulation of excitatory synapses
180. Pharmacological agents acting at subtypes of metabotropic glutamate receptors
181. Protective effects of group-I metabotropic glutamate receptor activation against hypoxic/hypoglicemic injury in rat hippocampal slices: Timing and involvement of protein kinase C
182. 2+ homeostasis and rescues cortical neurons from apoptotic death
183. Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus
184. Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor
185. The metabotropic glutamate receptor 1 is not involved in the facilitation of glutamate release in cerebro-cortical nerve terminals
186. Protein phosphatase 1 and 2A inhibitors prolong the switch in the control of glutamate release by group I metabotropic glutamate receptors: Characterization of the inhibitory pathway
187. Postsynaptic protein phosphorilation and LTP
188. Metabotropic glutamate receptor subtypes are differentially expressed after transient cerebral ischemia without, during and after tolerance induction in the gerbil hippocampus
189. Novel allosteric antagonists shed light on mGlu5 receptors and CNS disorders
190. Antagonists of group-I mGluRs attenuate exicitotoxic neuronal death in cortical cultures
191. Role of metabotropic glutamate receptors in the hypersusceptibility to pentylentetrazole-induced seizures during diazepam withdrawal
192. A family of metabotropic glutamate receptors
193. Prolonged anticonvulsant action of glutamate metabotropic receptor agonists in inferior colliculus of genetically epilepsy-prone rats
194. Alpha-methyl derivatives of serine-O-phosphate as novel, selective competitive metabotropic glutamate receptor antagonists
195. (2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine, a potent and selective antagonist of type 2 metabotropic glutamate receptors
196. Pentylenetetrazol-induced seizures increase 3H-L-2-amino-4-phosphonobutyrate binding in discrete regions of the rat bran
197. Transforming growth factor-beta is a survival factor for neonate cortical neurons: Coincident expression of type-1 receptors in developing cerebral cortices
198. Coupling of mGluR/Homer and PSD-95 coplexes by the Shank family of postsynaptic density proteins
199. Potentiation of NMDA and AMPA responses by the specific mGluR5 agonist CHPG in spinal cord motoneurons
200. SIB-1757 and SIB-1893: Selective, noncompetitive antagonists of metabotropic glutamate receptor type 5
201. Phenylglycine derivatives as antagonists of metabotropic glutamate receptors
202. The role of metabotropic glutamate receptor (mGluR) ligands in parkinsonian muscle rigidity
203. Localization of the human mGluR4 gene within an epilepsy susceptibility locus (1)
204. N-acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells
205. Competitive binding of alpha-actinin and calmodulin to the NMDA receptor
206. Homer: A link between neural activity and glutamate receptor function